Interestingly, whereas there are no significant differences between the patients with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes (T2D) in the lean population, the individuals with T2D have significantly higher expression levels of CES1 in the obese population (Fig 1I). The gene discussed is CES1; the disease is Impaired glucose tolerance.